合計 50 件の最近のインサイダー取引記録が記録されています Aeglea BioTherapeutics, Inc. (AGLE), 内訳は 35 件の買い および 8 件の売り. インサイダー買い総額は $29.2M インサイダー売り総額は $1.5M.
最近活動のある主要インサイダーには Fairmount Funds Management Llc, Burrows Scott L, Turtle Cameron. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — AGLE
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
その他（売り） |
3,435,480 |
- |
- |
- |
| 2023-12-22 |
Burrows Scott L |
Chief Financial Officer |
RSU 付与（制限付株式） |
134,953 |
- |
- |
134,953 |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
RSU 付与（制限付株式） |
16,667 |
- |
- |
16,667 |
| 2023-11-24 |
Turtle Cameron |
Chief Executive Officer |
転換（売り） |
18,086 |
- |
- |
- |
| 2023-11-24 |
Fairmount Funds Management Llc |
10 Percent Owner |
転換（売り） |
85,887 |
- |
- |
- |
| 2023-11-24 |
Albers Jeffrey W. |
Director |
転換（売り） |
859 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Officer |
不明 |
- |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
RSU 付与（制限付株式） |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Stelzer Laurie |
Officer |
不明 |
- |
- |
- |
- |
| 2023-11-22 |
Stelzer Laurie |
Director |
RSU 付与（制限付株式） |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Turtle Cameron |
Chief Executive Officer |
RSU 付与（制限付株式） |
374,000 |
$10.39 |
$3.89M |
374,000 |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
不明 |
34,360 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
RSU 付与（制限付株式） |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-09-01 |
King-jones Heidy |
Officer |
不明 |
- |
- |
- |
- |
| 2023-09-01 |
King-jones Heidy |
See Remarks |
RSU 付与（制限付株式） |
13,495,255 |
$0.58 |
$7.83M |
13,495,255 |
| 2023-09-01 |
Burrows Scott L |
Officer |
不明 |
- |
- |
- |
- |
| 2023-09-01 |
Burrows Scott L |
Chief Financial Officer |
RSU 付与（制限付株式） |
10,121,441 |
$0.58 |
$5.87M |
10,121,441 |
| 2023-06-22 |
Magovcevic-liebisch Ivana |
Director |
RSU 付与（制限付株式） |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Cox Russell J. |
Director |
RSU 付与（制限付株式） |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Lawton Alison Frances |
Director |
RSU 付与（制限付株式） |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Smith Hunter C |
Director |
RSU 付与（制限付株式） |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Turtle Cameron |
Chief Operating Officer |
処分 |
18,086,000 |
- |
- |
- |
| 2023-06-22 |
Henderson Michael Thomas |
Director |
処分 |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Fairmount Funds Management Llc |
10 Percent Owner |
不明 |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Alspaugh Jonathan |
President and CFO |
RSU 付与（制限付株式） |
19,787,969 |
$0.30 |
$5.94M |
19,787,969 |
| 2023-02-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
RSU 付与（制限付株式） |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Kastenmayer James Paul |
General Counsel |
RSU 付与（制限付株式） |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Alspaugh Jonathan |
Chief Financial Officer |
RSU 付与（制限付株式） |
640,000 |
$0.44 |
$281.6K |
640,000 |
| 2023-02-23 |
Neuman Linda L |
Chief Medical Officer |
RSU 付与（制限付株式） |
550,000 |
$0.44 |
$242K |
550,000 |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
不明 |
- |
- |
- |
- |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
RSU 付与（制限付株式） |
1,884,838 |
- |
- |
1,884,838 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
処分 |
- |
- |
- |
4,000 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
RSU 付与（制限付株式） |
25,000 |
- |
- |
25,000 |
| 2022-08-25 |
Souza Marcio |
Director |
情報に基づく買い |
90,000 |
$0.56 |
$50.47K |
90,000 |
| 2022-08-23 |
Sloan Leslie |
Chief Operating Officer |
RSU 付与（制限付株式） |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
RSU 付与（制限付株式） |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
処分 |
130,000 |
$7.03 |
$913.9K |
- |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
RSU 付与（制限付株式） |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Alspaugh Jonathan |
Chief Financial Officer |
RSU 付与（制限付株式） |
130,000 |
- |
- |
130,000 |
| 2022-06-08 |
Hanley Jr. Michael Conick |
Chief Commercial Officer |
情報に基づく買い |
28,200 |
$0.71 |
$20.02K |
36,200 |
| 2022-06-07 |
Lawlis V Bryan |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Magovcevic-liebisch Ivana |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Mahatme Sandesh |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Cox Russell J. |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Smith Hunter C |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Shanafelt Armen |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Souza Marcio |
Director |
RSU 付与（制限付株式） |
43,000 |
- |
- |
43,000 |
| 2022-06-07 |
Lawton Alison Frances |
Director |
RSU 付与（制限付株式） |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-03-16 |
Quinn Anthony G. |
President & CEO |
情報に基づく買い |
80,079 |
$2.34 |
$187.71K |
550,540 |
| 2022-03-15 |
Quinn Anthony G. |
President & CEO |
情報に基づく買い |
42,417 |
$1.86 |
$78.94K |
473,461 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
